FountainRx Specialty Pharmacy named leader by URAC
By HME News Staff
Updated 9:55 AM CDT, Tue June 30, 2026
MORRISTOWN, Tenn. – FountainRx Specialty Pharmacy has been recognized as a 2025 Pioneer in URAC’s Leaders in Performance Management (LPM) program, a distinction awarded to select URAC-accredited organizations committed to advancing health care quality through the measurement and improvement of patient care. "At FountainRx, we believe quality is more than a standard. It's a responsibility," said Joseph Huntsman, CEO and partner of FountainRx Specialty Pharmacy. "Every day, our team works to remove barriers to therapy, improve the patient experience, and support providers with the tools and communication they need. Being recognized by URAC as a Pioneer in Performance Measurement is a reflection of the dedication and compassion our team brings to every patient interaction." FountainRx says the recognition reflects its commitment to continuous improvement across every stage of the patient journey. By monitoring quality measures related to patient engagement, therapy adherence, access to treatment, operational performance, and clinical support, the company says it uses data-driven insights to improve care, reduce delays, and enhance outcomes for both patients and providers. Over the past six months, FountainRx says it has launched several initiatives to enhance patient and provider engagement, including its new FRxConnect patient and provider portals and a next-generation pharmacy management platform.
Comments